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other first-line antimicrobial agents:
the resistance rate is 0%–65.7% (4,5).
Therefore, clindamycin and trimetho-
prim/sulfamethoxazole may be not
adequate empiric antimicrobial agents
for SSTIs in Taiwan or other areas
with a high prevalence of CA-MRSA.
Jui-Shan Ma*
*Show-Chwan Memorial Hospital,
Changhua, Taiwan
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In response: Dr Ma makes an
excellent point about the limitations
of study data on antimicrobial drug
treatment of skin abscesses (1). All of
the patients described in our study (2)
required antimicrobial drug therapy,
and most were admitted to the hospi-
tal. However, we did not mean to
imply that all skin abscesses require
antimicrobial drug treatment. Our
own practice is to give antimicrobial
drug therapy only when a skin
abscess is associated with definite
surrounding cellulitis, systemic signs,
or both. Although various criteria
have been published, in practice this
is a judgment call, and we suspect
that physicians vary considerably in
use of antimicrobial agents for skin
infections.
Because most cellulitis associated
with skin abscess will improve with
adequate drainage, designing a study
that will find a difference in outcome
attributable to the antimicrobial drug
is difficult. More studies are needed to
determine whether antimicrobial
agents with in vitro activity against
methicillin-resistant  Staphylococcus
aureus  (MRSA) are more clinically
effective than those lacking such
activity. Perhaps these studies should
focus on those infections for which
antimicrobial agents would be expect-
ed to have the greatest impact (e.g.,
infected wounds with cellulitis),
rather than abscesses that can be
expected to improve with incision and
drainage alone.  
When the decision is made to use
an antimicrobial agent, it is difficult to
justify choosing one to which the
infecting organism will likely be
resistant. Because MRSA is now the
most common cause of skin infections
at our institution, we choose agents
with activity against the MRSA
strains in our community. We do not
believe that choosing an antimicrobial
agent to which the infecting organism
is susceptible is more likely to con-
tribute to the general problem of
antimicrobial drug resistance.  
Gregory J. Moran,* Ricky N. Amii,*
Frederick M. Abrahamian,* 
and David A. Talan*
*Olive View–UCLA Medical Center, Sylmar,
California, USA
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Angiostrongyliasis,
Mainland China 
To the Editor: The first case of
angiostrongyliasis caused by
Angiostrongylus cantonensis in main-
land China was reported in 1984; only
3 cases were reported between then
and 1996 (1). Recently, however,
cases of angiostrongyliasis have
increased rapidly because of its natu-
ral focus and a change in human
dietary patterns. For example, snails
have become a popular food in many
regions of this country. Nearly 100
cases of angiostrongyliasis have been
reported in mainland China, including
2 outbreaks (2,3). 
From 1994 to 2003, 84 cases of
angiostrongyliasis were documented
in mainland China. Of all the cases,
29 were reported individually, and 55
were reported from the 2 outbreaks
that occurred in Zhejiang and Fujian.
Sixty-three of the 84 patients had
eaten raw or undercooked snails, 5
had eaten raw crabs, 1 swallowed tad-
poles, and several pediatric patients
had close contact with snails. Some
researchers believe that the larvae of
A. cantonensis can be released from
mollusks into slime fluid and contam-
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inate produce and other objects as
they crawl. However, Liang et al. (4)
reported finding no larvae in body
fluid washed from 23 Achatina fulica
that were infected with A. cantonen-
sis. Therefore, whether slime fluid
plays a role in human infection
remains unclear. 
The clinical symptoms of the
patients from the 2 outbreaks of
angiostrongyliasis that occurred in
China are shown in the Table.
Eosinophilia is a typical characteristic
of eosinophilic meningitis or menin-
goencephalitis caused by A. cantonen-
sis. In our study, eosinophilia was
detected in 79 of 84 patients.
Therefore, clinical patients with
eosinophilic meningitis or meningoen-
cephalitis with eosinophilia should be
presumptively considered to be infect-
ed with A. cantonensis and parasito-
logic or serologic tests should be per-
formed. The parasitologic detection
rate of A. cantonensis infection in
humans is low; because this parasite is
found in the human central nervous
system (CNS) and the tiny larvae often
stick to meninges or nerve root, a
false-negative result is often shown
when cerebrospinal fluid is examined.
In the 84 cases reported in this article,
worms were isolated from only 8
patients (9.5%), whereas 64 cases
were diagnosed as angiostrongyliasis
by immunologic methods. The most
common immunologic methods used
to diagnosis angiostrongyliasis in this
country are indirect fluorescent anti-
body test, immunoenzymatic staining
technique, and enzyme-linked
immunosorbent assay. All antigens
used in these methods were prepared
from whole adult worms. Reports
indicated that serologic cross-reaction
occurred between trichinosis and
angiostrongyliasis when whole-worm
lysate was used as the antigen (5). In
addition, whole-worm antigens cannot
discriminate between new and previ-
ous infection, or monitor the efficacy
of the treatment. Therefore, finding
potential diagnostic antigens will be
essential to solving this problem and
applying recombinant antigens may
achieve this goal. A cDNA library
from the larvae of A. cantonensis was
constructed and screened with acute
infection sera, and a diagnostic anti-
gen that can detect early infection of
A. cantonensis (3 weeks) was identi-
fied (6). 
Some researchers considered that
anthelminthics, such as albendazole,
ivermectin, mebendazole, and pyran-
tel, did not affect A. cantonensis but
noted that the death of worms in the
CNS might exacerbate neurologic
symptoms (7). However, many stud-
ies in mainland China showed that
anthelminthics can relieve symptoms
and reduce the duration of disease.
For example, Wang et al. (8) reported
that albendazole could relieve the
symptoms of angiostrongyliasis and
suggested that it can be used to treat
the disease. Lin et al. (3) also reported
that in 8 patients who were treated
with 20 mg/kg albendazole for 9 days,
the symptoms and signs of acute
angiostrongyliasis were rapidly
relieved in 3–6 days. All of these
patients had recovered by 10 days
after treatment, and no side effects
were observed. 
Angiostrongyliasis is an emerging
foodborne public health problem in
mainland China. However, most clini-
cians are not familiar with this disease
and little is known about the preva-
lence of A. cantonensis in China.
Thus, more studies should be con-
ducted on the biology, epidemiology,
and clinical characteristics of
angiostrongyliasis, and more effective
diagnostic methods and treatments for
A. cantonensis should be developed.
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Methicillin-
resistant
Staphylococcus
aureus Necrotizing
Pneumonia
To the Editor: Methicillin-resist-
ant  Staphylococcus aureus (MRSA)
strains account for >40% of all hospi-
tal-acquired  S. aureus infections in
Italy (1). Although cases of communi-
ty-acquired MRSA (CA-MRSA)
infections have been reported in
recent years (2), these isolates have
not been characterized for Panton-
Valentine leukocidin (PVL) (3); there-
fore, the presence of isolates with the
typical characteristics of CA-MRSA
(4) in Italy remains unknown. 
At the beginning of April 2005, a
37-year-old woman was admitted to
the University Hospital Policlinico in
Rome because of fever, cough, and
headache. Her medical history was
unremarkable. She was a teacher in a
school for foreign students in Rome,
smoked 3 cigarettes per day for 15
years, and reported no recent travel
abroad. Her 5-year-old daughter had
influenzalike symptoms in the previ-
ous week. At hospital admission, her
temperature was 39°C, heart rate was
108 beats/min, respiratory rate was 32
breaths/min, and blood pressure was
105/70 mmHg. Arterial blood gas
analysis showed mild hypoxemia and
hypocapnia (PaO2 73 mm Hg and
PaCO2 34 mm Hg on room air).
Leukocyte count was 24,360 cells/µL
(81% polymorphonuclear cells), and
platelet count was 506,000/µL. Chest
radiograph showed infiltrates in the
right upper and lower lobes and left
lower lobe. Empiric treatment with
clarithromycin and ceftriaxone was
started, but the patient’s clinical con-
ditions did not improve. Culture of
sputum samples obtained at admis-
sion yielded growth of MRSA.
Computed tomographic scan showed
multiple lung cavitary lesions, indi-
cating necrotizing pneumonia. On day
3 of admission, antimicrobial drug
therapy was changed to linezolid (600
mg 3 times a day). Fever resolved,
and the patient’s condition rapidly
improved. The patient was discharged
after 14 days of linezolid treatment.
At discharge, leukocyte count was
6,040 cell/µL (58% polymorphonu-
clear cells), and arterial blood gas
analysis showed PaO2 of 88 mm Hg.
The MRSA isolate from sputum
was susceptible to all the non–β-lac-
tam antimicrobial drugs tested,
including erythromycin, clindamycin,
ciprofloxacin, tetracycline, kanamy-
cin, and fusidic acid. With established
molecular methods, the isolate was
found to harbor SCCmec type IV (5);
lukS and lukF, the genes coding for
the 2 subunits of the PVL toxin; and
hlg, the γ-hemolysin gene (3). The
genetic background of the isolate was
determined by multilocus sequence
typing (MLST) (6) and sequence typ-
ing of the tandem repeat region of
protein A gene (spa  typing) (7).
Results showed that the isolate
belonged to ST30 according to the
MLST database (http://saureus.
mlst.net), and spa typing, analyzed by
the Ridom Staphtype software
(http://www.ridom.de), indicated a
novel spa type, to which type 755 was
assigned. ST30, 1 of 6 clones more
commonly associated with PVL-posi-
tive CA-MRSA(4), is designated also
the southwest Pacific (SWP) clone,
because of the area in which it circu-
lates. Recently, the SWP clone has
caused CA-MRSA infections in
northern European countries
(England, Scotland, the Netherlands,
Sweden, and Latvia) (8,9). Molecular
analysis suggests that the SWP clone
has evolved from a methicillin-sus-
ceptible clone of S. aureus, termed
phage type 80/81, that was pandemic
in the 1950s and considered to be
unusually virulent and transmissible
(8). In fact, strains belonging to phage
type 80/81 carry the PVL gene and
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